Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 77869284Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2024
Linked Award Amount
$3.2M
Full award amounts, FY2024
Award Records
2
Records listing this PI
Award-Linked Rank
#2,336
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Patricio Sepulveda as a PI. Multi-PI records show the full award amount for context.
- 2R44NS124351-04R44Targeted DOK7 gene therapy for Congenital Myasthenic Syndromes$3Maward amount
- 5R42NS127713-02R42Targeted ColQ gene therapy for Congenital Myasthenic Syndromes$207.1Kaward amount
Award organization
Organizations that administered FY2024 awards listing Patricio Sepulveda as a PI.
FY2024 award administered by Amplo Biotechnology, Inc. (MD).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardAmplo Biotechnology, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #2336
- 2024Entered Top 25% NationallyRanked #2336
- 2026$5M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Patricio Sepulveda.